Cathy Burgess is quoted on the Food and Drug Administration’s continued focus on inspecting outsourcing facilities for pharmacy compounding and the promotion of cGMP requirements.
In the News
January 15, 2016
Bloomberg BNA | Outlook 2016: Drug Prices, User Fees, Biosimilars Among Key Topics
Media Contact